The effect of regadenoson-induced transient disruption of the blood–brain barrier on temozolomide delivery to normal rat brain

The blood–brain barrier (BBB) significantly reduces the delivery of many systemically administered agents to the central nervous system. Although temozolomide is the only chemotherapy to improve survival in patients with glioblastoma, its concentration in brain is only 20 % of that in blood. Regaden...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Neurooncol
Asıl Yazarlar: Jackson, Sadhana, Anders, Nicole M., Mangraviti, Antonella, Wanjiku, Teresia M., Sankey, Eric W., Liu, Ann, Brem, Henry, Tyler, Betty, Rudek, Michelle A., Grossman, Stuart A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4733584/
https://ncbi.nlm.nih.gov/pubmed/26626489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-015-1998-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller